PE84299A1 - Compuestos policiclicos parcialmente hidrogenados - Google Patents

Compuestos policiclicos parcialmente hidrogenados

Info

Publication number
PE84299A1
PE84299A1 PE00059998A PE00059998A PE84299A1 PE 84299 A1 PE84299 A1 PE 84299A1 PE 00059998 A PE00059998 A PE 00059998A PE 00059998 A PE00059998 A PE 00059998A PE 84299 A1 PE84299 A1 PE 84299A1
Authority
PE
Peru
Prior art keywords
ring
polyclic
compounds
partially hydrogenated
wavy lines
Prior art date
Application number
PE00059998A
Other languages
English (en)
Spanish (es)
Inventor
Jurg Zimmermann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE84299A1 publication Critical patent/PE84299A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
PE00059998A 1997-07-07 1998-07-03 Compuestos policiclicos parcialmente hidrogenados PE84299A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH164697 1997-07-07
CH214597 1997-09-11

Publications (1)

Publication Number Publication Date
PE84299A1 true PE84299A1 (es) 1999-09-09

Family

ID=25688257

Family Applications (1)

Application Number Title Priority Date Filing Date
PE00059998A PE84299A1 (es) 1997-07-07 1998-07-03 Compuestos policiclicos parcialmente hidrogenados

Country Status (4)

Country Link
AU (1) AU8856298A (fr)
CO (1) CO4940430A1 (fr)
PE (1) PE84299A1 (fr)
WO (1) WO1999002532A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19917990A1 (de) * 1999-04-20 2000-11-02 Florian Lang Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk
AU6014900A (en) 1999-07-13 2001-01-30 Kyowa Hakko Kogyo Co. Ltd. Staurosporin derivatives
FR2801054B1 (fr) * 1999-11-17 2003-06-13 Adir Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10042137A1 (de) * 2000-08-28 2002-03-14 Florian Lang sgk2 und sgk3 als diagnostische und therapeutische Targets
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) * 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
ATE369894T1 (de) * 2000-11-22 2007-09-15 Novartis Pharma Gmbh Kombination enthaltend ein mittel zur verminderung von vegf-aktivität und ein mittel zur verminderung von egf-aktivität
SK12022003A3 (sk) 2001-03-22 2004-05-04 Bristol-Myers Squibb Company Na topoizomerázu I selektívne cytotoxické cukrové deriváty indolpyrolkarbazolov
EP1439863B1 (fr) 2001-10-29 2011-01-12 Boehringer Ingelheim International GmbH Proteines homologues de mnk kinase impliquees dans la regulation de l'homeostase energetique et du metabolisme des organites
RU2337692C3 (ru) 2001-10-30 2020-11-09 Новартис Аг Производные стауроспорина в качестве ингибиторов активности рецепторной тирозинкиназы flt3
CA2478473A1 (fr) * 2002-01-25 2004-09-02 Pharmacia Corporation Therapie anti-aldosterones permettant de prevenir ou de traiter des troubles associes a une inflammation
WO2005014004A1 (fr) 2003-08-08 2005-02-17 Novartis Ag Combinaisons contenant des staurosporines
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
CN102101866A (zh) * 2010-11-04 2011-06-22 中国海洋大学 十字孢碱卤代衍生物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
EP0703917A1 (fr) * 1993-06-17 1996-04-03 Novartis AG Compose d'indolocarbazole utilise comme inhibiteur de proteine-kinase c
EP0763042A1 (fr) * 1994-06-01 1997-03-19 Novartis AG Derives de lactame polycyclique destines a sensibiliser a des agents antitumoraux des cellules a resistance multiple aux anticancereux
WO1997007081A2 (fr) * 1995-08-11 1997-02-27 Yale University Synthese d'indolocarbazols glycosyles

Also Published As

Publication number Publication date
WO1999002532A3 (fr) 1999-04-01
WO1999002532A2 (fr) 1999-01-21
CO4940430A1 (es) 2000-07-24
AU8856298A (en) 1999-02-08

Similar Documents

Publication Publication Date Title
PE84299A1 (es) Compuestos policiclicos parcialmente hidrogenados
FI910857A0 (fi) Foerfarande foer framstaellning av oxetanoner.
DE69613139T2 (de) Heterozyclische fungizide
FI970150A0 (fi) Substituoituja pyrimidiiniyhdisteitä ja niiden käyttö
BG103485A (en) Ketobanzamides as calpain inhibitors
AR006390A1 (es) Derivados de lactama
TR200102800T2 (tr) Yeni bileşikler.
BG106390A (en) Novel spiro compounds
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
TR200201684T2 (tr) Fenilpiperazinil türevleri
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
IT1271325B (it) Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni
DK0711291T3 (da) N-(Piperidinyl-1-alkyl)-substituerede cyclohexancarboxylsyreamider som 5-HT1A-receptorantagonister
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
BG105710A (en) 5ht1 antagonists for antidepressant therapy
ES2096941T3 (es) 27-hidroxirrapamicina y derivados de la misma.
EA200200727A1 (ru) Новые производные индола
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
DE69601451T2 (de) UCK14-Verbindungen
TR200001976T2 (tr) İzopropil-Metil [2-(3-n-propoksifenoksi)etil] amin'in hazırlanmasına yönelik usul
ATE165089T1 (de) Thiocarbamoylverbindungen als mikrobizide
ECSP982581A (es) Compuestos policiclicos parcialmente hidrogenados
TR199800171T1 (xx) �midazopiridin t�revleri.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal